Riskpilot← Back to searchSign inGet full accessBiomia ApS
APSActiveCVR 43616595Lersø Parkallé 44, 3.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20226 employeeswww.biomia.com
Revenue 2024
DKK -5,9M
+922% vs 2023
EBITDA margin
170.3%
-536% vs 2023
Equity ratio
73.1%
Financial strength
Net profit 2024
DKK -7,8M
-739% vs 2023
| Revenue | DKK -5,9M | +922% |
| EBITDA | DKK -10,1M | -536% |
| Net profit | DKK -7,8M | -739% |
| Total assets | DKK 15,5M | -21% |
| Equity | DKK 11,4M | -41% |
| Employees | 6 | — |
Legal name
Biomia ApS
CVR number
43616595
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. oktober 2022
Share capital
DKK 61.770
Employees
6 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsens formand, af direktøren i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive forskning og udvikling indenfor, og kommercialisering af, produktion af plantebaserede naturstoffer ved hjælp af bioteknologi.
Address
Lersø Parkallé 44, 3.
Website
www.biomia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | -582 | -5.944 |
| Staff expenses | -1.009 | -4.180 |
| EBITDA | -1.591 | -10.124 |
| Depreciation & amort. | -0 | -659 |
| EBIT | -1.591 | -10.783 |
| Net financials | 391 | 570 |
| Profit before tax | -1.200 | -10.213 |
| Tax | -267 | -2.388 |
| Net profit | -933 | -7.825 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 19.636 | 15.547 |
| Equity | 19.185 | 11.360 |
| Long-term debt | 0 | 2.336 |
| Short-term debt | 451 | 1.851 |
| Total debt | 451 | 4.187 |
EBITDA margin
-1012402000.0%
This company
15.8%
Market median
-6407607695% vs market
20232024
Equity ratio
73.1%
This company
38.2%
Market median
+91% vs market
20232024
Return on equity
-68.9%
This company
18.4%
Market median
-474% vs market
20232024
Net profit margin
-782520200.0%
This company
8.1%
Market median
-9660743310% vs market
20232024
Asset turnover
-0.38×
This company
1.12×
Market median
-134% vs market
20232024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20–24.99% | 20–24.99% | 2023 | |
| Company | 15–19.99% | 15–19.99% | 2022 | |
| Company | 15–19.99% | 15–19.99% | 2022 | |
| Company | 5–9.99% | 5–9.99% | 2022 | |
| Company | 5–9.99% | 5–9.99% | 2023 | |
| Company | 5–9.99% | 5–9.99% | 2022 | |
| Individual | 5–9.99% | 5–9.99% | 2023 | |
| Individual | 5–9.99% | 5–9.99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Next Stage Ventures ApS
Biomia ApS Board members of Biomia ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Krogh Jensen | Chief Executive Officer | 0 companies |
| Henrik Stage | Chairman | 0 companies |
| Jie Zhang | Board of Directors | 0 companies |
| Jay D Keasling | Board of Directors | 0 companies |